Scarica l'app Stockscreener
1.625
0.00%
0.025
Precedente Chiudi:
$1.65
Aprire:
$1.66
Volume 24 ore:
201.64K
Relative Volume:
0.77
Capitalizzazione di mercato:
$88.09M
Reddito:
-
Utile/perdita netta:
$-31.39M
Rapporto P/E:
-1.9345
EPS:
-0.84
Flusso di cassa netto:
$-18.45M
1 W Prestazione:
-7.82%
1M Prestazione:
+0.00%
6M Prestazione:
+55.66%
1 anno Prestazione:
+7.14%
Intervallo 1D:
$1.57
$1.6729
Intervallo di 1 settimana:
$1.57
$1.79
Portata 52W:
$0.7203
$2.45
Quince Therapeutics Inc Stock (QNCX) Company Profile
Nome
Quince Therapeutics Inc
Settore
Industria
Telefono
415-910-5717
Indirizzo
611 GATEWAY BLVD., SUITE 273, SOUTH SAN FRANCISCO
Confronta QNCX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
QNCX
Quince Therapeutics Inc
|
1.64 | 88.63M | 0 | -31.39M | -18.45M | -0.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.18 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
643.35 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.69 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
825.40 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.32 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Quince Therapeutics Inc Stock (QNCX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-05 | Iniziato | Citizens JMP | Mkt Outperform |
| 2025-03-24 | Iniziato | Oppenheimer | Outperform |
Quince Therapeutics Inc Borsa (QNCX) Ultime notizie
Sentiment analysis tools applied to Quince Therapeutics Inc.Trade Ideas & Verified Stock Trade Ideas - newser.com
Is Quince Therapeutics Inc. stock positioned for digital transformationQuarterly Portfolio Report & Safe Capital Growth Tips - newser.com
Is Quince Therapeutics Inc. stock oversold or undervaluedWeekly Gains Report & Verified Swing Trading Watchlist - newser.com
Will earnings trigger a reversal in Quince Therapeutics Inc.2025 Biggest Moves & Verified Entry Point Signals - newser.com
Is Quince Therapeutics Inc. stock a buy in volatile marketsPortfolio Return Report & Verified High Yield Trade Plans - newser.com
Why retail investors favor Quince Therapeutics Inc. stockTrade Signal Summary & Safe Entry Momentum Stock Tips - newser.com
What indicators show strength in Quince Therapeutics Inc.July 2025 Catalysts & Advanced Technical Signal Analysis - newser.com
How Quince Therapeutics Inc. stock performs in rising dollar environmentJuly 2025 Macro Moves & Community Verified Swing Trade Signals - newser.com
How to forecast Quince Therapeutics Inc. trends using time series2025 Buyback Activity & Free Long-Term Investment Growth Plans - newser.com
Statistical indicators supporting Quince Therapeutics Inc.’s strengthQuarterly Portfolio Review & Fast Exit and Entry Trade Guides - newser.com
Quince Therapeutics Inc. stock volume spike explainedPortfolio Profit Report & Smart Allocation Stock Tips - newser.com
Will Quince Therapeutics Inc. stock recover faster than peers2025 Market WrapUp & Community Trade Idea Sharing - newser.com
Can Quince Therapeutics Inc. stock double in next 5 yearsIPO Watch & Entry Point Strategy Guides - newser.com
What hedge fund activity signals for Quince Therapeutics Inc. stockQuarterly Growth Report & Free Reliable Trade Execution Plans - newser.com
How analysts rate Quince Therapeutics Inc. stock todayJuly 2025 PreEarnings & Precise Swing Trade Entry Alerts - newser.com
Is Quince Therapeutics Inc. stock cheap compared to fundamentalsWeekly Profit Recap & Pattern Based Trade Signal System - newser.com
Combining machine learning predictions for Quince Therapeutics Inc.Earnings Recap Report & Fast Gaining Stock Reports - newser.com
Is Quince Therapeutics Inc. showing signs of accumulationPrice Action & Safe Investment Capital Preservation Plans - newser.com
Is Quince Therapeutics Inc. stock ready for a breakoutMarket Growth Summary & Weekly Top Gainers Trade List - newser.com
Market reaction to Quince Therapeutics Inc.’s recent newsEarnings Trend Report & Daily Market Momentum Tracking - newser.com
Quince Therapeutics Inc Azioni (QNCX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.29%
0.16%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):